The researchers found that using phages on samples of MRSA produced a significant reduction in colony forming units of the bacteria, according the paper, published in the journal PLOS ONE.
“Our findings suggest that phage treatment can be used as an effective tool to decontaminate human MRSA from both hard surfaces and fabrics,” the authors wrote.
MRSA, which is typically resistant to many widely available antibiotics, is capable of causing serious disease and death in humans. To date, the Provo, Utah-based Brigham Young University researchers have identified six types of phages that are effective against MRSA.
More articles on infection control:
How lean can improve the quality, efficiency of OR instrument availability in 5 steps
Hospital beds get a makeover
Joint Commission launces educational campaign on antibiotic use
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
